Health Care
America has the most advanced health care in the world, in large part due to private sector-led innovation and employer-sponsored healthcare coverage.
While Americans benefit tremendously from ongoing advancements in bioscience, technology, and care, we continue to wrestle with the challenge of making quality health care more affordable, more accessible, and more reliable for all Americans. At the U.S. Chamber, we’re pushing for value-based healthcare solutions that reduce costs and reward quality outcomes.
Latest
Report
The United States is currently grappling with a nursing shortage that is causing a ripple effect of rising health care costs and lower quality of life across the country.
Spotlight on Mental Health
Become a part of the world’s largest business organization and network
U.S. Chamber members range from small businesses and chambers of commerce across the country to startups in fast-growing sectors, leading industry associations, and global corporations.
Discover the ROI Chamber membership can deliver for you.
Our Work
The U.S. Chamber is promoting effective private sector solutions to our health care challenges. These solutions will help control costs, expand access, and improve the quality of care. We support policy that strengthens the employer-based model of coverage, through which 180 million Americans receive—and overwhelmingly like—their health care.
Related Litigation
Latest Content
Major business trade organizations, health care advocacy group join campaign to protect employer-sponsored health coverage, raise awareness of threats posed by Medicare Buy-In or Public Option proposals.
America is where innovation thrives, and cutting-edge medicine is no exception. Right now, scientists are conducting more than 140,000 clinical trials across all 50 states to explore the potential of the therapeutics, vaccines, diagnostics, and cures we need to fight disease—from coronavirus to cancer.
Nine facts about about strengthening support for the employer-sponsored insurance (ESI) system.
This Hill letter was sent to Members of the House Judiciary Committee on H.R. 2891, the “Preserve Access to Affordable Generics and Biosimilars Act,” H.R. 2873, the “Affordable Prescriptions for Patients Act Through Promoting Competition Act,” and H.R. 2884, the “Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act.”
This coalition letter was sent to Members of the House of Representatives opposing H.R. 3, the "Lower Drug Costs Now Act of 2019."
Wellness and chronic disease management programs in the workplace play a critical role in improving the nation's health and productivity.
This Hill letter was sent to the Members of the U.S. House of Representatives on the Fiscal Year 2022 National Defense Authorization Act (NDAA).
WASHINGTON, D.C. - U.S. Chamber of Commerce Executive Vice President and Chief Policy Officer Neil Bradley released the following statement today after the White House announcement on drug pricing:
Private and public sector leaders discussed remedies to address these disparities.
WASHINGTON, D.C. - The following statement can be attributed to Glenn Spencer, Senior Vice President of Employment Policy Division, U.S. Chamber of Commerce.
